Ambulatory Care in Adult Congenital Heart Disease-Time for Change?

Louise Coats1,2, Bill Chaudhry3

  • 1Adult Congenital Heart Unit, Freeman Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne NE7 7DN, UK.

Insights

Adult congenital heart disease (ACHD) ambulatory care is costly and fails to prevent emergency admissions. New care delivery methods during COVID-19 warrant further investigation for improved patient outcomes.

Area of Science:

  • Cardiology
  • Public Health
  • Healthcare Management

Background:

  • The population with adult congenital heart disease (ACHD) is expanding, presenting increasing complexity.
  • Current ambulatory care practices for ACHD require evaluation for their effectiveness in problem detection and cost-efficiency.

Purpose of the Study:

  • To assess the adequacy of current ambulatory care in detecting problems within the growing ACHD population.
  • To evaluate the associated costs of existing ACHD ambulatory care models.

Main Methods:

  • A single-centre UK study analyzed clinic attendances for 100 ACHD patients from 2014-2019.
  • Data included patient demographics, appointment outcomes, diagnostic test results, hospital admissions, and travel impact.
  • The study also examined care delivery during the COVID-19 restrictions period (March 2020-July 2021).

Main Results:

  • Between 2014-2019, 575 appointments occurred with a 10% nonattendance rate; 80% yielded no decisions beyond continued review.
  • Diagnostic tests rarely identified new findings (5.1% ECG, 4.0% echo); decisions were more frequent in higher ACHD AP classes and symptomatic patients.
  • Emergency admissions (40) outnumbered elective (25), with over half following unremarkable appointments. Patient travel incurred significant workdays lost.
  • During COVID-19, 127 appointments (56% in-person, 41% telephone, 5% video) showed higher decision-making rates in in-person vs. virtual consultations (37% vs. 19%).

Conclusions:

  • ACHD clinics primarily serve surveillance purposes but currently do not effectively predict or prevent costly emergency hospital admissions.
  • Existing care models are associated with significant patient and provider costs.
  • The shift to alternative care delivery methods during COVID-19 necessitates further evaluation for optimizing ACHD patient management.
Abstract

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
51
Pulse rhythm01:30

Pulse rhythm

Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
952
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
75
Continuing Care01:25

Continuing Care

Continuing care describes the variety of health, personal, and social services provided over a prolonged period. The need for continuing care is increasing because people are living longer. Many people do not have families or others to care for them. Continuing care is mainly for patients who are disabled, functionally dependent, or suffering from a terminal disease. It is available within institutional settings or in homes. Examples include nursing centers or facilities, assisted living,...
1.6K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
43
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
45